News

Tesla lurches into the Musk robotics era

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Elon Musk

News

Editor's Top Picks

Anthropic doubles VC fundraising to $20bn on surging investor demand

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Anthropic is

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Sea Stock: This Is The Time To Make A Big Splashy Bet (NYSE:SE)

With the S&P 500 hovering around 12-month highs despite macro jitters, a common question investors

Deutsche wins credit card deal for Lufthansa frequent-flyer scheme

Receive free Deutsche Bank AG updatesWe’ll send you a myFT Daily Digest email rounding up

Colgate-Palmolive: Challenging Growth Prospects (NYSE:CL)

Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has

China on brink of consumer deflation

Receive free Chinese economy updatesWe’ll send you a myFT Daily Digest email rounding up the

Revenge Of The Mini-Me. Oracle, Rivian, And Advanced Micro – I Explain

These 3 are smaller than the competition, make no mistake they bring a lot to

From TSMC to Samsung, Asia’s chipmakers struggle to go green

Insufficient access to renewable energy in their home markets has left Asia’s biggest chipmakers lagging

Aldeyra (ALDX): Navigating The Future Of Eye Disease Treatment With Reproxalap

Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases.

Gautam Adani: the Indian billionaire vs the short seller

You can enable subtitles (captions) in the video player The story of Adani is the

Biogen And Alzheimer’s Disease: Too Early To Celebrate (NASDAQ:BIIB)

On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB)

SVB Financial sues US banking regulator to recover $1.9bn

Receive free SVB Financial Group updatesWe’ll send you a myFT Daily Digest email rounding up

Eli Lilly: The Party Is Likely Over (NYSE:LLY)

Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its

Live news: Asian equities rise after Yellen’s visit to China raises hopes of thaw in relations

© AP The US and Germany are under intense pressure from other allies to show

Burberry: Shares Move Closer To Fair Value Amid Lingering Headwinds (OTCMKTS:BBRYF)

Luxury fashion house Burberry (OTCPK:BURBY) (OTCPK:BBRYF) was facing some headwinds when I last covered it

China’s youth left behind as jobs crisis mounts

Job opportunities scream from posters at an employment fair in central China’s Zhengzhou. “Join us

Green Thumb Industries: Future Catalysts Sum Up The Bull Case (OTCMKTS:GTBIF)

Investment Thesis Green Thumb Industries (OTCQX:GTBIF) is one of the largest US multi-state operators (MSO)